| 1 |
34264023 | HO-1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy. | 2022 Mar |
1 |
| 2 |
34856444 | Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway. | 2022 Feb |
1 |
| 3 |
35327653 | The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study. | 2022 Mar 17 |
5 |
| 4 |
35464301 | All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells. | 2022 Jun |
5 |
| 5 |
35468014 | Luteolin attenuated cisplatin-induced cardiac dysfunction and oxidative stress via modulation of Keap1/Nrf2 signaling pathway. | 2022 Feb |
2 |
| 6 |
35490795 | Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells. | 2022 Apr 29 |
6 |
| 7 |
35505963 | miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways. | 2022 Jun 14 |
1 |
| 8 |
35580917 | Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling. | 2022 May 17 |
2 |
| 9 |
35626727 | Activation of MT1/MT2 to Protect Testes and Leydig Cells against Cisplatin-Induced Oxidative Stress through the SIRT1/Nrf2 Signaling Pathway. | 2022 May 19 |
1 |
| 10 |
33148531 | Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells. | 2021 Feb |
1 |
| 11 |
33219317 | UFBP1, a key component in ufmylation, enhances drug sensitivity by promoting proteasomal degradation of oxidative stress-response transcription factor Nrf2. | 2021 Jan |
1 |
| 12 |
33610575 | Vincamine protects against cisplatin induced nephrotoxicity via activation of Nrf2/HO-1 and hindering TLR4/ IFN-γ/CD44 cells inflammatory cascade. | 2021 May 1 |
1 |
| 13 |
33735393 | Sensitization of A-549 lung cancer cells to Cisplatin by Quinacrine-loaded lipidic nanoparticles via suppressing Nrf2 mediated defense mechanism. | 2021 Jul |
2 |
| 14 |
33771701 | Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance. | 2021 May |
1 |
| 15 |
34080212 | Combination of cyanidin-3-O-glucoside and cisplatin induces oxidative stress and apoptosis in HeLa cells by reducing activity of endogenous antioxidants, increasing bax/bcl-2 mRNA expression ratio, and downregulating Nrf2 expression. | 2021 Jul |
1 |
| 16 |
34098867 | Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling. | 2021 Jun 7 |
3 |
| 17 |
34237431 | Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells. | 2021 Sep 10 |
1 |
| 18 |
34239803 | Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma. | 2021 |
2 |
| 19 |
34320371 | The developmental origin of cancers defines basic principles of cisplatin resistance. | 2021 Oct 28 |
1 |
| 20 |
34407971 | Recurrent Human Papillomavirus-Related Head and Neck Cancer Undergoes Metabolic Reprogramming and Is Driven by Oxidative Phosphorylation. | 2021 Nov 15 |
1 |
| 21 |
34673143 | Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. | 2021 Dec |
1 |
| 22 |
34786050 | Bladder cancer cells prevent cisplatin-induced oxidative stress by upregulating Nestin1 expression. | 2021 |
1 |
| 23 |
30787448 | Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human. | 2020 Apr |
1 |
| 24 |
31583720 | Deregulation of UCA1 expression may be involved in the development of chemoresistance to cisplatin in the treatment of non-small-cell lung cancer via regulating the signaling pathway of microRNA-495/NRF2. | 2020 Apr |
2 |
| 25 |
31791583 | MBNL1 regulates resistance of HeLa cells to cisplatin via Nrf2. | 2020 Feb 12 |
2 |
| 26 |
31897145 | Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway. | 2020 Jan |
6 |
| 27 |
31974389 | The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity. | 2020 Jan 23 |
1 |
| 28 |
31983246 | Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling. | 2020 Nov |
2 |
| 29 |
32012470 | MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma. | 2020 Mar |
4 |
| 30 |
32088177 | Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory. | 2020 May 5 |
2 |
| 31 |
32092292 | Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury. | 2020 May |
1 |
| 32 |
32102425 | Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to Cisplatin. | 2020 Feb 24 |
2 |
| 33 |
32206093 | Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer. | 2020 |
1 |
| 34 |
32394538 | Cytoplasmic, but not nuclear Nrf2 expression, is associated with inferior survival and relapse rate and response to platinum-based chemotherapy in non-small cell lung cancer. | 2020 Jul |
3 |
| 35 |
32428544 | Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production. | 2020 Oct 1 |
7 |
| 36 |
32574971 | The effect of monotropein on alleviating cisplatin-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis. | 2020 Sep |
1 |
| 37 |
32800561 | Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway. | 2020 Oct 20 |
1 |
| 38 |
32814771 | Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation. | 2020 Aug 20 |
2 |
| 39 |
32817372 | GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. | 2020 Aug 18 |
1 |
| 40 |
32927432 | Metformin suppresses Nrf2-mediated chemoresistance in hepatocellular carcinoma cells by increasing glycolysis. | 2020 Sep 14 |
1 |
| 41 |
32945421 | Panax notoginseng Saponins protect auditory cells against cisplatin‑induced ototoxicity by inducing the AKT/Nrf2 signaling‑mediated redox pathway. | 2020 Oct |
2 |
| 42 |
33041661 | Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway. | 2020 |
1 |
| 43 |
33066634 | Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells. | 2020 Oct 14 |
4 |
| 44 |
33232319 | LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1. | 2020 |
3 |
| 45 |
33290263 | Enhancer-bound Nrf2 licenses HIF-1α transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells. | 2020 Dec 3 |
6 |
| 46 |
33294122 | The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer. | 2020 |
1 |
| 47 |
33489797 | Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2. | 2020 Dec |
2 |
| 48 |
30030687 | NRAL mediates cisplatin resistance in hepatocellular carcinoma via miR-340-5p/Nrf2 axis. | 2019 Mar |
5 |
| 49 |
30668336 | Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression. | 2019 Mar 15 |
4 |
| 50 |
30811078 | The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. | 2019 Nov |
3 |